Millions of people around the world use cannabis on a daily basis for a myriad of illnesses.
This plant is helping many veterans with PTSD, it's helping a great deal of children who suffer from daily seizures as a result of their epilepsy, it's been helping millions who suffer from regular pain as a result of their chronic diseases, and a heck of a lot more.
Industry experts suggest that when it comes to understanding cannabis, the medical studies are limited in a number of ways, because of the federal prohibition that has existed for some time. However, as legalization has spread there has been an increase in the available research on the subject and researchers suggest that there could be potential for cannabis to be valuable in treating serious mental health issues and much more.
Researchers have for many years now accredited cannabis with having anti-inflammatory properties and now a majority of the states in the US have legalized it for either recreational or medical purposes. Thanks to the move to further understand the potential benefits that cannabis could offer, not just in the US but world-wide, researchers have now realized that it might show promise when it comes to treating tourette syndrome, Alzheimer's disease, and schizophrenia.
Specifically, it's CBD that scientists say might be the most beneficial in providing relief for conditions like schizophrenia.
And CBD is a product that can be produced that doesn't contain the psychoactive THC component that gets people 'high' and this is what has made the CBD product ideal for children and others who are nervous to try consuming cannabis for the first time.
Researchers from Australia recently suggested that CBD might prove useful in treating a wide range of conditions; CBD can offer valuable neurological support.
Those researchers found that chronic administration of the CBD contributed to what they saw as a reduction of social withdrawal and cognitive deficits. Not only that, but they also suggest that the CBD contributed to a noticeable restoration of working memory and recognition.
Scientists claim that the majority of the anti-psychotic medications that are on the market today come along with negative side effects like weight-gain (and worse), and that about 80 percent of those medications don't address the cognitive deficits. Not only did they see CBD address the cognitive deficits but they also didn't see that weight-gain side effect with the CBD.
Cannabis has proven to be beneficial in many ways and according to those who use it, it's responsible for drastically improving their standard of living when it comes to dealing with a variety of symptoms. Considering this then, it's quite frustrating to see that despite the remedy that millions have been able to reap from this plant, there remain many people who are unapologetic about their position against this plant and anything that it has to offer.
You don't have to like or support cannabis, that is your choice.
However, you can be against cannabis and that doesn't mean that you also need to try and prevent other people from making their own choice; from consuming cannabis if they want to.
Pics:
Iriana Shiyan Shutterstock via reset.me/story/beyond-thc-and-cbd-the-health-benefits-of-terpenes/
Giphy via giphy.com/gifs/colorado-cannabis-denver-10XphtxVxC1rQ4
Clipart Panda via clipartpanda.com/clipart_images/urgent-care-clinic-in-gilbert-22643249
The information that is posted above is not intended or implied to ever be used as any substitute for professional medical advice, or diagnosis or treatment. The above is posted for informational purposes only.
Sources:
https://www.sciencedaily.com/releases/2008/07/080720222549.htm
https://www.sciencedaily.com/releases/2017/05/170524131139.htm
https://www.forbes.com/sites/janetwburns/2017/08/28/cannabis-shows-promise-in-treating-schizophrenia-and-tourette-syndrome/#3bb32c3463de
Related Posts:
Drug Use And Human Rights
https://steemit.com/writing/@doitvoluntarily/drug-use-and-human-rights
2016 Cannabis Sales Surpass $6.7 Billion
https://steemit.com/cannabis/@doitvoluntarily/2016-cannabis-sales-surpass-usd6-7-billion